DHP for Mitigating HAI Risk:
C-Suite & Epidemiology Insights
Register For Our Webinar on June 25
June 25, 2025 at 1pm EDT
Eric Ramos, MD, FAAFP and Chris Lee, Infectious Disease Epidemiologist will address the critical issue of healthcare-associated infections (HAIs) and present a practical, evidence-based solution in Synexis’ patented Dry Hydrogen Peroxide (DHP®) for mitigating their risk. Join Dr. Ramos and Lee for this webinar that will include a Q&A session including pathogen-related inquiries, ROI/case-building, and implementation questions.
What you’ll gain from attending this webinar:
- An understanding of the financial and operational impact of HAIs from a C-Suite perspective
- Clinical evidence supporting DHP as an Infection Prevention Solution
- A practical strategy for implementing Synexis’ patented DHP technology in healthcare settings
- Q&A Session
Meet the Presenters
Dr. Eric Ramos, MD, FAAFP
Eric Ramos, MD, FAAFP, is a highly motivated healthcare executive with comprehensive knowledge and experience leading healthcare teams. Dr. Ramos served as Chief Medical Officer (CMO)at Memorial Medical Center in Modesto, CA, and the Northern California Group for Tenet Healthcare. In addition to having previously served as CMO and Medical Director for Doctors Medical Center, he has served as CMO of Long Beach Medical Center in Los Angeles County and CMO of HCA’s Far West Division, where he led clinical excellence programs at division hospitals.
Dr. Ramos’ career in healthcare leadership involved helping hospitals optimize the quality of care through rigorous outcome measurements and performance improvement processes. He firmly believes that high-level goals are achieved through team building, strategic planning, improving operational efficiencies, and front-line accountability.
Chris Lee, Infectious Disease Epidemiologist
Chris Lee, Infectious Disease Epidemiologist, obtained his Master’s in Public Health with a specialization in Epidemiology from The Ohio State University in 2020. Since then, Chris has operated as an independent consultant within the biodefense and healthcare sectors, helping his clients design and implement studies pertaining to microbial risk assessment.
Chris obtained his Master’s in Business Administration from Indiana University in 2023, igniting a passion for helping his clients jointly pursue their technical and corporate goals.
